GAMMACORE

Migraine and Headache Awareness Month: gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Treats & Prevents Migraine and Cluster Headaches

Retrieved on: 
Tuesday, June 8, 2021
General Health, Health, Other Health, Medical devices, Headaches, Symptoms and signs, Medicine, Clinical medicine, Trigeminal autonomic cephalgia, Migraine, Medication overuse headache, Hemicrania continua, Cluster headache, Headache, International Classification of Headache Disorders, NIH classification of headaches, electroCore, Inc, gammaCore, ELECTROCORE, INC, GAMMACORE

Successful treatment with gammaCore may generate savings for patients and provide overall benefit by preventing attacks, reducing pain intensity and frequency.

Key Points: 
  • Successful treatment with gammaCore may generate savings for patients and provide overall benefit by preventing attacks, reducing pain intensity and frequency.
  • gammaCore may also help reduce medical costs for migraine including frequent doctors visits and pharmaceuticals or other treatments.
  • The companys current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.
  • gammaCore is CE-marked in the European Union for the acute and/or prophylactic treatment of primary headache (Migraine, Cluster Headache, Trigeminal Autonomic Cephalalgias and Hemicrania Continua) and Medication Overuse Headache in adults.

The Ins & Outs of nVNS: Non-Invasive Vagus Nerve Stimulation Device Prevents and Relieves Pain From Migraines, Cluster Headaches & Other Conditions

Retrieved on: 
Monday, May 24, 2021
Biotechnology, Medical devices, Health, Science, Research, Branches of biology, Neuroscience, Neurotechnology, Neuroprosthetics, Electrotherapy, Vagus nerve, ElectroCore, Neuromodulation, Functional electrical stimulation, VNS, Peripheral nerve interface, Transcutaneous electrical nerve stimulation, electroCore, Inc., gammaCore, ELECTROCORE, INC., GAMMACORE

While vagus nerve stimulation (VNS) has been available for decades, electroCore has transformed the industry with non-invasive vagus nerve stimulation (nVNS) therapy which taps into the power and potential of the vagus nerve via a portable device.

Key Points: 
  • While vagus nerve stimulation (VNS) has been available for decades, electroCore has transformed the industry with non-invasive vagus nerve stimulation (nVNS) therapy which taps into the power and potential of the vagus nerve via a portable device.
  • Implanted Vagus Nerve Stimulation (iVNS), which involves the surgical implantation of a device, was one of the first major breakthroughs highlighting how electrical stimulation could be used to treat conditions such as depression, epilepsy, infectious disease, and heart disease.
  • In 2008, electroCore joined this medical exploration and two years later created a non-invasive way of delivering VNS therapy.
  • What makes non-invasive nerve stimulation so exciting is the ability for the patient to self-administer the treatment, says Dr. Staats.

electroCore, Inc. Celebrates Veterans and Active Members of the Military During National Military Appreciation Month

Retrieved on: 
Thursday, May 20, 2021
Seniors, Defense, Physical therapy, Other Defense, Health, Mental health, Medical devices, Consumer, Branches of biology, Nervous system, Neuroscience, Abdomen, Autonomic nervous system, Gustatory system, Vagus nerve, Pain, electroCore, Inc., gammaCore, ELECTROCORE, INC., GAMMACORE

b'National Military Appreciation Month commemorates and expresses gratitude for the sacrifices current and former members of the U.S. armed forces have made for our country\xe2\x80\x99s freedom.

Key Points: 
  • b'National Military Appreciation Month commemorates and expresses gratitude for the sacrifices current and former members of the U.S. armed forces have made for our country\xe2\x80\x99s freedom.
  • The vagus nerve serves as the communication superhighway carrying information between the brain and internal organs and has a direct role in regulating pain in the human body.
  • "\ngammaCore Sapphire is available through the VA and in military treatment facilities at no charge to patients through Federal Supply Schedule (FSS) eligible entities which covers over nine million veterans and active military personnel.
  • Designed as a portable, easy-to-use technology, gammaCore can be self-administered by patients, as needed, without the potential side effects associated with commonly prescribed drugs.

electroCore Supports Results of Lancet Paper Highlighting the Benefits of Vagus Nerve Stimulation for Stroke Patients

Retrieved on: 
Tuesday, May 18, 2021
Medical devices, Health, Infectious diseases, Other Health, General Health, Biotechnology, Branches of biology, Anatomy, Neuroscience, Stroke, Vagus nerve stimulation, Vagus nerve, VNS, electroCore, Inc., gammaCore, ELECTROCORE, INC., GAMMACORE

Effective treatments hold particular interest because stroke is the second highest cause of death and the third leading cause of disability globally, with ischemic stroke as the most common type of stroke.

Key Points: 
  • Effective treatments hold particular interest because stroke is the second highest cause of death and the third leading cause of disability globally, with ischemic stroke as the most common type of stroke.
  • In this clinical trial, patients with moderate-to-severe arm impairment after ischemic stroke participated in rehabilitation for two years after the implantation of VNS.
  • Wermer and Dr. Van Der Meij describe current research regarding the potential for non-invasive vagus nerve stimulation (nVNS) as another option for treating stroke, although no results are published yet.
  • \xc2\xa7 360bbbb-3(b)(1), until the authorization is terminated or revoked.\nMore information can be found at:\nFact sheet for healthcare workers: https://www.fda.gov/media/139968/download\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210518005193/en/\n'